凯立新材(688269) - 2025 Q2 - 季度财报

Company Profile and Key Financial Indicators This section provides an overview of the company's basic information and presents its key accounting data and financial performance indicators Company Overview Xi'an Kaili New Materials Co., Ltd. (Kaili New Materials, 688269) is a new materials company led by Zeng Yongkang, registered and operating in Xi'an Economic and Technological Development Zone, Shaanxi Province - Company's Chinese name is Xi'an Kaili New Materials Co., Ltd., stock code 688269, listed on the STAR Market of Shanghai Stock Exchange[13][16] - Mr. Zeng Yongkang has been appointed as the legal representative of the company[13] Key Accounting Data and Financial Indicators During the reporting period, the company achieved operating revenue of 1.014 billion yuan, a 24.86% increase, and net profit attributable to parent of 61.2 million yuan, up 30.83%, driven by increased catalyst sales and optimized business structure, though net cash flow from operating activities significantly decreased to -91.18 million yuan due to increased receivables and raw material purchases Key Accounting Data (yuan) | Key Accounting Data | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | Net Profit Attributable to Shareholders of Listed Company | 61,195,291.25 | 46,776,124.61 | 30.83 | | Net Profit Attributable to Shareholders of Listed Company After Deducting Non-Recurring Gains and Losses | 63,294,359.78 | 42,552,326.99 | 48.74 | | Net Cash Flow from Operating Activities | -91,179,720.04 | 35,190,791.64 | -359.10 | Key Financial Indicators | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (yuan/share) | 0.47 | 0.36 | 30.56 | | Basic Earnings Per Share After Deducting Non-Recurring Gains and Losses (yuan/share) | 0.48 | 0.33 | 45.45 | | Weighted Average Return on Net Assets (%) | 5.86 | 4.62 | Increased by 1.24 percentage points | | R&D Investment as Percentage of Operating Revenue (%) | 2.34 | 2.72 | Decreased by 0.38 percentage points | - Operating revenue growth primarily due to a 122.33% year-on-year increase in overall catalyst product sales, with sales in the pharmaceutical and basic chemical sectors growing by 49.26% and 185.54% respectively[19] - Net cash flow from operating activities significantly decreased by 359.10%, mainly due to increased accounts receivable from expanded sales and higher raw material procurement expenses to meet production orders[22] Management Discussion and Analysis This section provides an in-depth discussion of the company's industry position, operational performance, core competencies, and key risk factors Industry and Main Business The company, a leading precious metal catalyst enterprise in fine chemicals, expanded into basic chemicals and environmental new energy, achieving significant sales growth of 49.26% in pharmaceuticals, 185.54% in basic chemicals, and 1497.06% in environmental new energy - The company is a leader and technology pioneer in precious metal catalysts within the fine chemical sector, with business synergistically developing around "catalyst preparation and catalytic application technology", forming three major business segments: R&D and production, technology development, and recycling and reprocessing[27] - During the reporting period, the company achieved significant sales growth across all major business areas: - Pharmaceutical Sector: Sales increased by 49.26% year-on-year, primarily due to increased demand from core customers and enhanced market share[29] - Basic Chemical Sector: Sales increased by 185.54% year-on-year, mainly benefiting from a 113.22% increase in PVC mercury-free catalyst sales and new product promotion[30] - Environmental New Energy Sector: Sales surged by 1497.06% year-on-year, primarily due to significant progress in hydrogen energy catalysts and establishing partnerships with leading water electrolysis hydrogen production enterprises[32] Discussion and Analysis of Operations In H1 2025, the company made significant progress in strategy, R&D, marketing, and production, forming a "three locations, four zones" synergistic development pattern, advancing R&D digitalization, expanding market reach, and enhancing operational efficiency through automation - Strategic Layout: The company has formed a "Caotan, Jingwei, Tongchuan, Binzhou" three locations, four zones synergistic development pattern. The main construction of the Binzhou Kaitai Hydrogenated Nitrile Butadiene Rubber industrialization project has been completed and entered the commissioning phase[35] - Technology R&D: In H1 2025, 23 new invention patent applications were filed, with a cumulative total of 191 authorized patents. The company strengthened R&D digitalization, utilizing AI simulation and prediction to guide catalyst R&D[36][37] - Market Marketing: While consolidating its leading position in fine chemicals, sales in the basic chemical sector increased by 185.54% year-on-year. The company is also accelerating its global layout, actively collaborating with overseas customers[38][39] - Production Operations: Multiple automated demonstration production lines were established, and the automation upgrade of the PVC mercury-free catalyst carbon carrier treatment production line was completed, enhancing operational efficiency[39][40] Analysis of Core Competencies The company's core competencies span six areas: institutional mechanisms, technology R&D, products, talent, brand and customer base, and service advantages, with continuous R&D investment, 23.75 million yuan in expensed R&D in H1, and 173 cumulative invention patents, focusing on cutting-edge projects to address "bottleneck" issues and achieve import substitution - Company's core competencies include: 1. Institutional Mechanism Advantage: State-controlled background with core employee stock ownership[43] 2. Technology and R&D Advantage: Synergistic development of catalyst and catalytic application technology, possessing national-level research platforms[44] 3. Product Advantage: Comprehensive product range with excellent performance, covering fine chemicals, basic chemicals, energy, and environmental protection[46] 4. Talent Advantage: Stable and professional core management and technical team[47] 5. Brand and Customer Advantage: Nearly a thousand users, including a hundred listed companies, with high brand recognition[49] 6. Service Advantage: Provides integrated full-process services from R&D and production to recycling[49] - New progress in core technologies, including the activation of advanced scientific research systems introducing AI simulation and prediction, development of new platinum-carbon and ruthenium-based catalysts, breakthroughs in precious metal valence state control technology, and collaboration with Dalian Institute of Chemical Physics, Chinese Academy of Sciences on single-atom catalysts[50] R&D Investment | R&D Investment | Current Period (yuan) | Prior Period (yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Expensed R&D Investment | 23,753,649.66 | 22,120,503.73 | 7.38 | | Total R&D Investment | 23,753,649.66 | 22,120,503.73 | 7.38 | | Total R&D Investment as Percentage of Operating Revenue (%) | 2.34 | 2.72 | Decreased by 0.38 percentage points | - As of the end of the reporting period, the company has cumulatively obtained 173 invention patents and 16 utility model patents. During the reporting period, 23 new invention patent applications were filed, and 4 were granted[54][55] Risk Factors The company faces core risks from rapid technological iteration and competitive gaps, operational risks from volatile precious metal prices and high capital occupation, and financial risks including accounts receivable impairment and gross margin fluctuations, alongside industry-specific precious metal resource scarcity and macroeconomic policy changes - Core Competitiveness Risk: The industry experiences rapid technological upgrades and iterations; if the company fails to continuously maintain technological advancement, it may face risks of declining competitiveness[69][70] - Operational Risk: Platinum group precious metals, as primary raw materials, are subject to significant price fluctuations and high costs, accounting for over 90% of production costs, posing challenges to the company's cost and inventory management. Downstream pharmaceutical customers are affected by policies like "4+7" volume-based procurement, which may demand cost reductions or new process development, placing higher requirements on the company's products[71][72] - Financial Risk: At the end of the reporting period, the book value of accounts receivable increased, intensifying working capital occupation and bad debt risks. Concurrently, changes in business structure and raw material costs may lead to gross margin fluctuations[74] - Industry Risk: China's platinum group metal resources are scarce, primarily relying on imports; if international political factors affect supply, it will significantly impact the company's production and operations[75] Analysis of Key Operating Performance During the reporting period, operating revenue and cost increased by 24.86% and 22.58% respectively, while financial expenses surged by 238.97% due to increased short-term borrowings for raw material procurement; accounts receivable and financing receivables grew significantly, reflecting expanded sales and enhanced collection management, with Tongchuan Kaili contributing significantly to profit Key Operating Data (yuan) | Item | Current Period | Prior Period | Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | Operating Cost | 892,657,605.31 | 728,200,539.69 | 22.58 | | Financial Expenses | 6,970,526.86 | 2,056,372.86 | 238.97 | | Net Cash Flow from Operating Activities | -91,179,720.04 | 35,190,791.64 | -359.10 | - Financial expenses increased by 238.97% year-on-year, primarily due to increased short-term borrowings for raw material procurement during the reporting period, leading to higher interest expenses[79] Assets/Liabilities Items (yuan) | Asset/Liability Item | Current Period End | Prior Period End | Change (%) | | :--- | :--- | :--- | :--- | | Accounts Receivable | 227,181,414.79 | 155,833,042.87 | 45.79 | | Accounts Receivable Financing | 105,160,602.64 | 56,777,284.20 | 85.22 | | Long-term Borrowings | 150,250,215.91 | 115,000,000.00 | 30.65 | - As of the end of the reporting period, the company's total restricted assets amounted to 405 million yuan, mainly comprising fixed assets, intangible assets, and construction in progress pledged for borrowings[84][85] Corporate Governance, Environment, and Society This section details changes in the company's board, senior management, and core technical personnel Changes in Directors, Supervisors, Senior Management, and Core Technical Personnel During the reporting period, the company experienced several senior personnel changes, including Mr. Zhang Zhixiang's retirement as Chairman, succeeded by Mr. Zeng Yongkang, and Ms. Wang Shihong's resignation as CFO and Board Secretary, succeeded by Mr. Zeng Lihui, with no changes in core technical personnel - Mr. Zhang Zhixiang resigned as Chairman due to retirement but continues to serve as a core technical personnel[93] - Mr. Zeng Yongkang was elected as the new Chairman and became the company's legal representative[93] - Mr. Zeng Lihui was appointed as Deputy General Manager, Chief Financial Officer, and Board Secretary[93][94] Significant Matters This section outlines the fulfillment of commitments, significant related party transactions, and major contracts and their performance Fulfillment of Commitments During the reporting period, the company's actual controller, shareholders, related parties, and the company itself strictly adhered to all commitments made during the initial public offering, including share lock-up, holding intentions, avoidance of horizontal competition, and standardization of related party transactions, with no violations - Commitments made by the company's controlling shareholder Northwest Institute, directors, senior management, and core technical personnel, such as share lock-up, were timely and strictly fulfilled during or continuing into the reporting period[101][102][103] Significant Related Party Transactions During the reporting period, the company engaged in daily operational related party transactions, including sales of products and services totaling 23.65 million yuan to Xi'an Taijin New Energy Technology Co., Ltd. and 4.15 million yuan to Western Metal Materials Co., Ltd., all within the estimated amounts Related Party Transaction Categories | Related Party Transaction Category | Related Party | Estimated Amount (million yuan) | Actual Amount During Reporting Period (million yuan) | | :--- | :--- | :--- | :--- | | Sales of Products, Goods, and Services to Related Parties | Xi'an Taijin New Energy Technology Co., Ltd. and its controlled companies | 6,000.00 | 2,365.39 | | | Western Metal Materials Co., Ltd. and its controlled companies | 4,000.00 | 414.91 | | | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 500.00 | 230.14 | | Acceptance of Services from Related Parties | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 285.00 | 133.64 | Significant Contracts and Their Fulfillment During the reporting period, the company provided joint liability guarantees totaling up to 400 million yuan for its wholly-owned subsidiary Tongchuan Kaili, with a remaining guarantee balance of 81.75 million yuan at period-end, representing 8.11% of net assets, all within approved limits and without overdue external guarantees - The company provided two guarantees for its wholly-owned subsidiary Tongchuan Kaili, totaling 130 million yuan, for working capital and fixed asset borrowings[130] - At the end of the reporting period, the total guarantee balance for subsidiaries was 81.75 million yuan, representing 8.11% of the company's net assets[130] Share Changes and Shareholder Information This section details the company's shareholder structure and key shareholder information Shareholder Information As of the end of the reporting period, the company had 5,848 common shareholders, with the top ten shareholder structure remaining stable, and controlling shareholder Northwest Institute for Non-ferrous Metal Research holding 25.71%, alongside core management and institutional investors like social security and pension funds - As of the end of the reporting period, the company had a total of 5,848 common shareholders[136] Shareholder Information | Shareholder Name | Shares Held at Period End | Percentage (%) | | :--- | :--- | :--- | | Northwest Institute for Non-ferrous Metal Research | 33,600,000 | 25.71 | | Zhang Zhixiang | 5,506,632 | 4.21 | | Huatai-PineBridge Fund Management Co., Ltd. - Social Security Fund 17022 Portfolio | 3,390,598 | 2.59 | | Basic Pension Insurance Fund 16032 Portfolio | 1,996,684 | 1.53 | | Wang Pengbao | 1,755,800 | 1.34 | Financial Report This section presents the company's consolidated financial statements and selected notes, providing a detailed view of its financial position and performance Consolidated Financial Statements As of June 30, 2025, the company's total assets were 2.164 billion yuan, up 5.50% from the beginning of the period, with total liabilities of 1.114 billion yuan, operating revenue of 1.014 billion yuan, and net profit of 61.13 million yuan, while operating cash flow was a net outflow of 91.18 million yuan and financing cash flow a net inflow of 83.54 million yuan Balance Sheet Items (yuan) | Balance Sheet Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Total Assets | 2,164,106,653.29 | 2,051,340,758.70 | | Total Liabilities | 1,114,456,952.16 | 999,321,050.54 | | Total Equity Attributable to Parent Company Owners | 1,007,544,973.82 | 1,013,485,099.31 | Income Statement Items (yuan) | Income Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Total Operating Revenue | 1,014,440,234.28 | 812,448,045.42 | | Total Operating Cost | 949,209,029.82 | 774,611,538.17 | | Total Profit | 69,075,853.22 | 51,426,288.86 | | Net Profit | 61,125,409.71 | 46,747,372.85 | Cash Flow Statement Items (yuan) | Cash Flow Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -91,179,720.04 | 35,190,791.64 | | Net Cash Flow from Investing Activities | -77,892,281.49 | -204,531,931.44 | | Net Cash Flow from Financing Activities | 83,535,800.37 | 139,032,604.15 | Notes to Financial Statements (Excerpt) Financial statement notes detail account composition and changes, including 230 million yuan in cash and equivalents (with 12.1 million yuan restricted), 227 million yuan in accounts receivable (up 45.79%), 338 million yuan in inventory, and operating revenue primarily from catalyst sales, with 23.75 million yuan in expensed R&D - Cash and equivalents at period-end totaled 230 million yuan, of which 12.1 million yuan was restricted as bank guarantee deposits[286] - Accounts receivable at period-end had a book balance of 240 million yuan, with a book value of 227 million yuan after deducting 12.47 million yuan for bad debt provisions[295][298] Operating Revenue Composition (yuan) | Operating Revenue Composition | Revenue (yuan) | Cost (yuan) | | :--- | :--- | :--- | | Main Business | 941,830,136.94 | 822,391,027.08 | | Of which: Catalyst Sales | 873,814,904.71 | 792,148,143.05 | | Catalyst Processing | 67,676,536.82 | 30,160,369.20 | | Other Business | 72,610,097.34 | 70,266,578.23 | | Total | 1,014,440,234.28 | 892,657,605.31 | - Total R&D expenses during the reporting period were 23,753,649.66 yuan, primarily comprising employee compensation (10.78 million yuan) and material costs (6.52 million yuan), all expensed[419][446]